168 related articles for article (PubMed ID: 26778639)
1. A description of Medical Examiner prescription-related deaths and prescription drug monitoring program data.
Lev R; Petro S; Lee O; Lucas J; Stuck A; Vilke GM; Castillo EM
Am J Emerg Med; 2016 Mar; 34(3):510-4. PubMed ID: 26778639
[TBL] [Abstract][Full Text] [Related]
2. Methadone related deaths compared to all prescription related deaths.
Lev R; Petro S; Lee A; Lee O; Lucas J; Castillo EM; Egnatios J; Vilke GM
Forensic Sci Int; 2015 Dec; 257():347-352. PubMed ID: 26513639
[TBL] [Abstract][Full Text] [Related]
3. Who is prescribing controlled medications to patients who die of prescription drug abuse?
Lev R; Lee O; Petro S; Lucas J; Castillo EM; Vilke GM; Coyne CJ
Am J Emerg Med; 2016 Jan; 34(1):30-5. PubMed ID: 26476578
[TBL] [Abstract][Full Text] [Related]
4. Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.
De Marco Centeno P; Baig M; Lee SE; Lane CJ; Lagomasino IT
J Psychiatr Pract; 2015 Nov; 21(6):412-8. PubMed ID: 26554323
[TBL] [Abstract][Full Text] [Related]
5. Drug poisoning deaths in the United States, 1980-2008.
Warner M; Chen LH; Makuc DM; Anderson RN; Miniño AM
NCHS Data Brief; 2011 Dec; (81):1-8. PubMed ID: 22617462
[TBL] [Abstract][Full Text] [Related]
6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
7. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
[TBL] [Abstract][Full Text] [Related]
8. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?
Smith RJ; Kilaru AS; Perrone J; Paciotti B; Barg FK; Gadsden SM; Meisel ZF
Pain Med; 2015 Jun; 16(6):1122-31. PubMed ID: 25688454
[TBL] [Abstract][Full Text] [Related]
9. Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program.
Delcher C; Wagenaar AC; Goldberger BA; Cook RL; Maldonado-Molina MM
Drug Alcohol Depend; 2015 May; 150():63-8. PubMed ID: 25746236
[TBL] [Abstract][Full Text] [Related]
10. Prescription drug fatalities among women in rural Virginia: a study of medical examiner cases.
Wunsch MJ; Nakamoto K; Nuzzo PA; Behonick G; Massello W; Walsh SL
J Opioid Manag; 2009; 5(4):228-36. PubMed ID: 19736903
[TBL] [Abstract][Full Text] [Related]
11. Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program Data.
Hildebran C; Leichtling G; Irvine JM; Cohen DJ; Hallvik SE; Deyo RA
Pain Med; 2016 Nov; 17(11):2061-2066. PubMed ID: 27009292
[TBL] [Abstract][Full Text] [Related]
12. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
13. Using textual cause-of-death data to study drug poisoning deaths.
Ossiander EM
Am J Epidemiol; 2014 Apr; 179(7):884-94. PubMed ID: 24521559
[TBL] [Abstract][Full Text] [Related]
14. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
[TBL] [Abstract][Full Text] [Related]
15. High mortality rate of unintentional poisoning due to prescription opioids in adults enrolled in Medicaid compared to those not enrolled in Medicaid in Montana.
Fernandes JC; Campana D; Harwell TS; Helgerson SD
Drug Alcohol Depend; 2015 Aug; 153():346-9. PubMed ID: 26077605
[TBL] [Abstract][Full Text] [Related]
16. Exploring coronial determination of intent for poisoning-related deaths in Australia, 2001-2013.
Churruca K; Mitchell R
BMC Public Health; 2017 Aug; 18(1):83. PubMed ID: 28764673
[TBL] [Abstract][Full Text] [Related]
17. Prescriber response to unsolicited prescription drug monitoring program reports in Massachusetts.
Thomas CP; Kim M; Nikitin RV; Kreiner P; Clark TW; Carrow GM
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):950-7. PubMed ID: 24920376
[TBL] [Abstract][Full Text] [Related]
18. Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(2):257-66. PubMed ID: 26143489
[TBL] [Abstract][Full Text] [Related]
19. Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse.
Norwood CW; Wright ER
Res Social Adm Pharm; 2016; 12(3):509-14. PubMed ID: 26329535
[TBL] [Abstract][Full Text] [Related]
20. Preparing a prescription drug monitoring program data set for research purposes.
O'Kane N; Hallvik SE; Marino M; Van Otterloo J; Hildebran C; Leichtling G; Deyo RA
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):993-7. PubMed ID: 27273809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
